Business Standard

Friday, December 27, 2024 | 06:12 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's board approves borrowing of Rs 2,000 cr through multiple routes

DRL's board also the approved sale of the Contract Development and Manufacturing Organisation(CDMO) division of Custom Pharmaceutical Services (CPS), on a slump sale basis

reddy, dr reddy's
Premium

The company is allowed to pursue any of the multiple modes available for raising the money

BS Reporter Hyderabad
The board of Dr Reddy's Laboratories Limited (DRL) on Friday approved company borrowings of up to an aggregate amount of Rs 2,000 crore in one or more transches. For the purpose, the company is allowed to pursue any of the multiple modes available such as issuance of commercial paper, debentures, bonds and/ or through bank credit lines, term loans including external commercial borrowings that it may deem fit, according to a stock exchange filing.

Dr Reddy's board, at its meeting on Friday, also the approved sale of the Contract Development and Manufacturing Organisation(CDMO) division of Custom Pharmaceutical Services (CPS), on a
Topics : Dr Reddys

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in